Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.145 USD | -0.24% | -11.29% | -56.03% |
03/04 | Stifel Cuts Price Target on Verve Therapeutics to $40 From $56, Maintains Buy Rating | MT |
02/04 | Sector Update: Health Care Stocks Slide Late Afternoon | MT |
- Stock Market
- Equities
- VERV Stock
- News Verve Therapeutics, Inc.